This study explored whether visual field mean deviation (MD) on standard static perimetry is a reliable predictor of visual outcome in patients with idiopathic intracranial hypertension (IIH). Source: AAO
This week, Luxturna approaches EU approval, Novartis’ brolucizumab outperforms aflibercept in neovascular AMD trials and NIDEK unveils a “groundbreaking” gonioscopy device that performs 360-degree iridocorneal angle imaging in full color. Source: AAO
In this study, researchers compared complication rates arising from primary and secondary intra-arterial chemotherapy (IAC) treatment of retinoblastoma. Source: AAO
Stephen Lane, MD, shared full results from the post-approval COMPASS-XT study at the 2018 ESCRS meeting in Lisbon, Portugal. The long-term safety data offers new insights into Alcon’s decision to withdraw the CyPass microstent from global markets last month. Source: AAO
This paper reports results from a phase 2 trial evaluating oral valproic acid for treating autosomal dominant retinitis pigmentosa. Source: AAO
This large retrospective analysis compared the rotational stability of the Acrysoft and Tecnis toric IOLs. Source: AAO
The FDA awarded fast track designation to a single-administration, intravitreal gene therapy for wet AMD, according to a press release by Adverum Biotechnologies. Source: AAO
This study assessed the diagnostic accuracy of 3D high-resolution T1-weighted black-blood magnetic resonance imaging (T1-BB-MRI) for the detection of posterior ciliary artery involvement in patients with giant cell arteritis and funduscopic arteritic anterior ischemic optic neuropathy (A-AION). Source: AAO
This observational study estimated annual Medicare Part B spending on 2 anti-VEGF drugs. Source: AAO
This study reports the outcomes of silicone Ahmed glaucoma valve (AGV) implantation in the management of refractory pediatric glaucoma. Source: AAO
Tel: 518-580-0553
Get Directions »
Tel: 518-580-0553
Get Directions »
Tel: +1 (518) 580-0553
Get Directions »
